Abstract:Glycosylated polyene macrolides include effective antifungal agents, such as pimaricin, nystatin, candicidin, and amphotericin B. For the treatment of systemic mycoses, amphotericin B has been described as a gold-standard antibiotic because of its potent activity against a broad spectrum of fungal pathogens, which do not readily become resistant. However, amphotericin B has severe toxic side effects, and the development of safer alternatives remains an important objective. One approach towards obtaining such compounds is to discover new related natural products. Advances in next-generation sequencing have delivered a wealth of microbial genome sequences containing polyene biosynthetic gene clusters. These typically encode a modular polyketide synthase that catalyzes the assembly of the aglycone core, a cytochrome P450 that oxidizes a methyl branch to a carboxyl group, and additional enzymes for synthesis and attachment of a single mycosamine sugar residue. In some cases, further P450s catalyze epoxide formation or hydroxylation within the macrolactone. Bioinformatic analyses have identified over 250 of these clusters. Some are predicted to encode potentially valuable new polyenes that have not been uncovered by traditional screening methods. Recent experimental studies have characterized polyenes with new polyketide backbones, previously unknown late oxygenations, and additional sugar residues that increase water-solubility and reduce hemolytic activity. Here we review these studies and assess how this new knowledge can help to prioritize silent polyene clusters for further investigation. This approach should improve the chances of discovering better antifungal antibiotics.

A new polyene macrolide antibiotic, machidamycin, produced by Streptomyces sp. K22-0017

New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived Streptomyces sp. KKMA-0239

Two New P-Methoxyphenyl-type Derivatives from a Saline-Lake Derived Streptomyces Sp. XZB32.

Strepolyketide D, a New SEK15-derived Polyketide Compound from Salt-Lake-derived Streptomyces Sp. DBC5.

Discovery of Three 22-Membered Macrolides by Deciphering the Streamlined Genome of Mangrove-Derived Streptomyces Sp. HM190

Derivatives of Holomycin and Cyclopropaneacetic Acid from Streptomyces Sp Dt-A37

New Polyene Macrolide Compounds from Mangrove-Derived Strain Streptomyces hiroshimensis GXIMD 06359: Isolation, Antifungal Activity, and Mechanism against Talaromyces marneffei

Paenimacrolidin, a Novel Macrolide Antibiotic from Paenibacillus Sp. F6‐B70 Active Against Methicillin‐resistant Staphylococcus Aureus

A New Medermycin Analog from the Marine-Derived Actinomycetes Streptomyces Sp. ZS-A45.

MDN-0170, a New Napyradiomycin from Streptomyces sp. Strain CA-271078

Structure and Biosynthesis of Mayamycin B, a New Polyketide with Antibacterial Activity from Streptomyces Sp. 120454

Dactylides A−C, three new bioactive 22-membered macrolides produced by Dactylosporangium aurantiacum

Antimicrobial spiroketal macrolides and dichloro-diketopiperazine from Micromonospora sp. FIMYZ51

A new polycyclic tetramate macrolactam from Allostreptomyces RD068384: stereochemistry and antifungal potential

New Glycosylated Polyene Macrolides: Refining the Ore from Genome Mining

New antimalarial iromycin analogs produced by Streptomyces sp. RBL-0292

Aldgamycins Q 1 and Q 2, two novel 16-membered macrolides from the rare actinomycete Saccharothrix sp. 16Sb2-4

MDN-0171, a new medermycin analogue from Streptomyces albolongus CA-186053

Engineered Biosynthesis of Disaccharide-Modified Polyene Macrolides

New Ikarugamycin Derivatives with Antifungal and Antibacterial Properties from Streptomyces zhaozhouensis

Argenteolides A and B, Glycosylated Polyketide–Peptide Hybrid Macrolides from an Actinomycete Streptomyces Argenteolus